Report Detail

Pharma & Healthcare Global (United States, European Union and China) Bronchodilators Market Research Report 2019-2025

  • RnM3689548
  • |
  • 22 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or requires prescription. Basically there are available in three forms injectable, oral and inhaled. In oral forms they come in variety such as liquids, tablets and capsules, these oral forms are delivered in higher doses which is directly absorbed into the bloodstream and so they have relatively more side effects. Whereas inhaled once are directly deposited in the lungs causing less side effects. Bronchodilators are of basically-acting or long-acting beta2-agonists and anticholinergic agents or theophylline. They function so as to control asthma and COPD. Short acting bronchodilators function for fast relief of asthma symptoms and long acting bronchodilators function for control symptoms of asthma.
Increase in prevalence of pulmonary disorders, smoking, and junk food fuel the bronchodilators market growth. In addition, rise in disposable income, geriatric population, and increase in awareness of healthcare among population are anticipated to boost the market growth. However, side effects associated with bronchodilators and government regulations related to the safety & efficacy of the bronchodilators hinder the market. Ongoing R&D activities related to bronchodilators are anticipated to present new opportunities for the market.
North America is expected to be the largest market for bronchodilators due to high incidence rate of diseases such as COPD and asthma, high demand for bronchodilator drugs, and increase in awareness. Europe holds the second largest market share. The Asia Pacific market is expected to provide a lucrative opportunity during the forecast period due to increasing disease burden, growing biopharmaceutical industry, and rising research activity along with competitive landscape in the pharmaceutical industry. The market in Latin America and Middle East & Africa is anticipated to grow owing to increasing health care infrastructure and growing public-private collaboration to expand the health care sector.
In 2019, the market size of Bronchodilators is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bronchodilators.

This report studies the global market size of Bronchodilators, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bronchodilators sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
F. Hoffmann-La Roche
...

Market Segment by Product Type
Anticholinergic Bronchodilators
Adrenergic Bronchodilators
Bronchodilator Combinations
Methylxanthines

Market Segment by Application
Asthma
COPD
Others 

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Bronchodilators status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bronchodilators manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Bronchodilators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Bronchodilators Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Anticholinergic Bronchodilators
      • 1.3.3 Adrenergic Bronchodilators
      • 1.3.4 Bronchodilator Combinations
      • 1.3.5 Methylxanthines
    • 1.4 Market Segment by Application
      • 1.4.1 Global Bronchodilators Market Share by Application (2019-2025)
      • 1.4.2 Asthma
      • 1.4.3 COPD
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Bronchodilators Market Size
      • 2.1.1 Global Bronchodilators Revenue 2014-2025
      • 2.1.2 Global Bronchodilators Sales 2014-2025
    • 2.2 Bronchodilators Growth Rate by Regions
      • 2.2.1 Global Bronchodilators Sales by Regions 2014-2019
      • 2.2.2 Global Bronchodilators Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Bronchodilators Sales by Manufacturers
      • 3.1.1 Bronchodilators Sales by Manufacturers 2014-2019
      • 3.1.2 Bronchodilators Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Bronchodilators Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bronchodilators Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Bronchodilators Market Concentration Ratio (CR5 and HHI)
    • 3.3 Bronchodilators Price by Manufacturers
    • 3.4 Key Manufacturers Bronchodilators Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Bronchodilators Market
    • 3.6 Key Manufacturers Bronchodilators Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Anticholinergic Bronchodilators Sales and Revenue (2014-2019)
      • 4.1.2 Adrenergic Bronchodilators Sales and Revenue (2014-2019)
      • 4.1.3 Bronchodilator Combinations Sales and Revenue (2014-2019)
      • 4.1.4 Methylxanthines Sales and Revenue (2014-2019)
    • 4.2 Global Bronchodilators Sales Market Share by Type
    • 4.3 Global Bronchodilators Revenue Market Share by Type
    • 4.4 Bronchodilators Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Bronchodilators Sales by Application

    6 United States

    • 6.1 United States Bronchodilators Breakdown Data by Company
    • 6.2 United States Bronchodilators Breakdown Data by Type
    • 6.3 United States Bronchodilators Breakdown Data by Application

    7 European Union

    • 7.1 European Union Bronchodilators Breakdown Data by Company
    • 7.2 European Union Bronchodilators Breakdown Data by Type
    • 7.3 European Union Bronchodilators Breakdown Data by Application

    8 China

    • 8.1 China Bronchodilators Breakdown Data by Company
    • 8.2 China Bronchodilators Breakdown Data by Type
    • 8.3 China Bronchodilators Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Bronchodilators Breakdown Data by Company
    • 9.2 Rest of World Bronchodilators Breakdown Data by Type
    • 9.3 Rest of World Bronchodilators Breakdown Data by Application
    • 9.4 Rest of World Bronchodilators Breakdown Data by Countries
      • 9.4.1 Rest of World Bronchodilators Sales by Countries
      • 9.4.2 Rest of World Bronchodilators Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 AstraZeneca
      • 10.1.1 AstraZeneca Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Bronchodilators
      • 10.1.4 Bronchodilators Product Introduction
      • 10.1.5 AstraZeneca Recent Development
    • 10.2 Boehringer Ingelheim
      • 10.2.1 Boehringer Ingelheim Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Bronchodilators
      • 10.2.4 Bronchodilators Product Introduction
      • 10.2.5 Boehringer Ingelheim Recent Development
    • 10.3 GlaxoSmithKline
      • 10.3.1 GlaxoSmithKline Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Bronchodilators
      • 10.3.4 Bronchodilators Product Introduction
      • 10.3.5 GlaxoSmithKline Recent Development
    • 10.4 F. Hoffmann-La Roche
      • 10.4.1 F. Hoffmann-La Roche Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Bronchodilators
      • 10.4.4 Bronchodilators Product Introduction
      • 10.4.5 F. Hoffmann-La Roche Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Bronchodilators Sales Channels
      • 11.2.2 Bronchodilators Distributors
    • 11.3 Bronchodilators Customers

    12 Market Forecast

    • 12.1 Global Bronchodilators Sales and Revenue Forecast 2019-2025
    • 12.2 Global Bronchodilators Sales Forecast by Type
    • 12.3 Global Bronchodilators Sales Forecast by Application
    • 12.4 Bronchodilators Forecast by Regions
      • 12.4.1 Global Bronchodilators Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Bronchodilators Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Bronchodilators. Industry analysis & Market Report on Bronchodilators is a syndicated market report, published as Global (United States, European Union and China) Bronchodilators Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Bronchodilators market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,614.16
      3,921.24
      5,228.32
      3,050.40
      4,575.60
      6,100.80
      501,446.40
      752,169.60
      1,002,892.80
      273,650.40
      410,475.60
      547,300.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report